A Compassion-Focused Ecological Momentary Intervention for Enhancing Resilience in Help-Seeking Youth: Uncontrolled Pilot Study.
adolescent psychopathology
digital interventions
ecological momentary assessment
mental health
mobile health
mobile phone
self-compassion
Journal
JMIR mental health
ISSN: 2368-7959
Titre abrégé: JMIR Ment Health
Pays: Canada
ID NLM: 101658926
Informations de publication
Date de publication:
05 Aug 2021
05 Aug 2021
Historique:
received:
10
11
2020
accepted:
25
05
2021
revised:
27
04
2021
entrez:
12
8
2021
pubmed:
13
8
2021
medline:
13
8
2021
Statut:
epublish
Résumé
Digital interventions offer new avenues for low-threshold prevention and treatment in young people. Ecological momentary interventions (EMIs) represent a powerful approach that allows for adaptive, real-time, and real-world delivery of intervention components in daily life by real-time processing of ecological momentary assessment (EMA) data. Compassion-focused interventions (CFIs) may be particularly amenable to translation into an EMI to strengthen emotional resilience and modify putative risk mechanisms, such as stress sensitivity, in the daily lives of young help-seeking individuals. This study aims to investigate the feasibility, safety, and initial therapeutic effects of a novel, accessible, transdiagnostic, ecological momentary CFI for improving emotional resilience to stress (EMIcompass). In this uncontrolled pilot study, help-seeking youth with psychotic, depressive, or anxiety symptoms were offered the EMIcompass intervention in addition to treatment as usual. The EMIcompass intervention consisted of a 3-week EMI (including enhancing, consolidating, and EMA-informed interactive tasks) administered through a mobile health app and three face-to-face sessions with a trained psychologist intended to provide guidance and training on the CFI exercises presented in the app (ie, training session, follow-up booster session, and review session). In total, 10 individuals (mean age 20.3 years, SD 3.8; range 14-25) were included in the study. Most (8/10, 80%) participants were satisfied and reported a low burden of app usage. No adverse events were observed. In approximately one-third of all EMAs, individuals scored high on stress, negative affect, or threat anticipation during the intervention period, resulting in real-time, interactive delivery of the CFI intervention components in addition to weekly enhancing and daily consolidating tasks. Although the findings should be interpreted with caution because of the small sample size, reduced stress sensitivity, momentary negative affect, and psychotic experiences, along with increased positive affect, were found at postintervention and the 4-week follow-up. Furthermore, reductions in psychotic, anxiety, and depressive symptoms were found (r=0.30-0.65). Our findings provide evidence on the feasibility and safety of the EMIcompass intervention for help-seeking youth and lend initial support to beneficial effects on stress sensitivity and mental health outcomes. An exploratory randomized controlled trial is warranted to establish the feasibility and preliminary evidence of its efficacy.
Sections du résumé
BACKGROUND
BACKGROUND
Digital interventions offer new avenues for low-threshold prevention and treatment in young people. Ecological momentary interventions (EMIs) represent a powerful approach that allows for adaptive, real-time, and real-world delivery of intervention components in daily life by real-time processing of ecological momentary assessment (EMA) data. Compassion-focused interventions (CFIs) may be particularly amenable to translation into an EMI to strengthen emotional resilience and modify putative risk mechanisms, such as stress sensitivity, in the daily lives of young help-seeking individuals.
OBJECTIVE
OBJECTIVE
This study aims to investigate the feasibility, safety, and initial therapeutic effects of a novel, accessible, transdiagnostic, ecological momentary CFI for improving emotional resilience to stress (EMIcompass).
METHODS
METHODS
In this uncontrolled pilot study, help-seeking youth with psychotic, depressive, or anxiety symptoms were offered the EMIcompass intervention in addition to treatment as usual. The EMIcompass intervention consisted of a 3-week EMI (including enhancing, consolidating, and EMA-informed interactive tasks) administered through a mobile health app and three face-to-face sessions with a trained psychologist intended to provide guidance and training on the CFI exercises presented in the app (ie, training session, follow-up booster session, and review session).
RESULTS
RESULTS
In total, 10 individuals (mean age 20.3 years, SD 3.8; range 14-25) were included in the study. Most (8/10, 80%) participants were satisfied and reported a low burden of app usage. No adverse events were observed. In approximately one-third of all EMAs, individuals scored high on stress, negative affect, or threat anticipation during the intervention period, resulting in real-time, interactive delivery of the CFI intervention components in addition to weekly enhancing and daily consolidating tasks. Although the findings should be interpreted with caution because of the small sample size, reduced stress sensitivity, momentary negative affect, and psychotic experiences, along with increased positive affect, were found at postintervention and the 4-week follow-up. Furthermore, reductions in psychotic, anxiety, and depressive symptoms were found (r=0.30-0.65).
CONCLUSIONS
CONCLUSIONS
Our findings provide evidence on the feasibility and safety of the EMIcompass intervention for help-seeking youth and lend initial support to beneficial effects on stress sensitivity and mental health outcomes. An exploratory randomized controlled trial is warranted to establish the feasibility and preliminary evidence of its efficacy.
Identifiants
pubmed: 34383687
pii: v8i8e25650
doi: 10.2196/25650
pmc: PMC8380580
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e25650Subventions
Organisme : EPA
ID : EP-C-13-022
Pays : United States
Informations de copyright
©Christian Rauschenberg, Benjamin Boecking, Isabell Paetzold, Koen Schruers, Anita Schick, Thérèse van Amelsvoort, Ulrich Reininghaus. Originally published in JMIR Mental Health (https://mental.jmir.org), 05.08.2021.
Références
J Affect Disord. 2016 Oct;203:101-110
pubmed: 27285723
Schizophr Res. 2005 Nov 1;79(1):117-25
pubmed: 16276559
Behav Res Ther. 2002 Aug;40(8):961-79
pubmed: 12186358
PLoS One. 2016 Mar 15;11(3):e0150205
pubmed: 26978655
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
World Psychiatry. 2016 Jun;15(2):118-24
pubmed: 27265696
Arch Gen Psychiatry. 2001 Dec;58(12):1137-44
pubmed: 11735842
Clin Psychol Rev. 2007 May;27(4):409-24
pubmed: 17222489
Early Interv Psychiatry. 2013 Feb;7(1):31-43
pubmed: 22672533
Br J Clin Psychol. 2018 Jun;57(2):240-254
pubmed: 29044607
Psychol Med. 2020 May 22;:1-11
pubmed: 32438944
JMIR Mhealth Uhealth. 2016 Sep 15;4(3):e103
pubmed: 27634747
Curr Opin Psychiatry. 2016 Jul;29(4):258-63
pubmed: 27153125
Psychoneuroendocrinology. 2018 Oct;96:61-68
pubmed: 29906787
Schizophr Bull. 2013 Jul;39(4):884-95
pubmed: 22258881
Schizophr Bull. 2019 Jun 18;45(4):871-882
pubmed: 30189093
Br J Health Psychol. 2010 Feb;15(Pt 1):1-39
pubmed: 19646331
Psychol Med. 2019 Jun;49(8):1378-1391
pubmed: 30282569
J Affect Disord. 2020 Feb 15;263:413-419
pubmed: 31969272
Schizophr Bull. 2009 Sep;35(5):865-73
pubmed: 19661198
Psychol Med. 2016 Oct;46(13):2799-813
pubmed: 27400863
Annu Rev Clin Psychol. 2016;12:249-80
pubmed: 26772205
Front Psychol. 2019 Feb 01;10:152
pubmed: 30774614
Trials. 2019 Dec 26;20(1):769
pubmed: 31878966
Acta Psychiatr Scand. 2017 Oct;136(4):373-388
pubmed: 28758672
Soc Psychiatry Psychiatr Epidemiol. 2016 Mar;51(3):319-26
pubmed: 26687237
JMIR Ment Health. 2019 Feb 20;6(2):e9819
pubmed: 30785404
Trends Cogn Sci. 2015 Oct;19(10):590-602
pubmed: 26412097
Behav Res Ther. 2020 May;128:103592
pubmed: 32146218
Psychol Med. 2006 Aug;36(8):1109-18
pubmed: 16734944
Ann Behav Med. 2018 May 18;52(6):446-462
pubmed: 27663578
Am J Psychiatry. 2013 Jul;170(7):695-8
pubmed: 23820827
Schizophr Bull. 2018 Feb 15;44(2):328-337
pubmed: 28338969
World Psychiatry. 2019 Feb;18(1):67-76
pubmed: 30600629
Lancet Psychiatry. 2017 Oct;4(10):775-818
pubmed: 28946952
Psychol Med. 2012 May;42(5):1003-12
pubmed: 22067414
World Psychiatry. 2018 Oct;17(3):282-293
pubmed: 30229571
Br J Psychiatry. 2016 Aug;209(2):107-13
pubmed: 26989099
J Abnorm Psychol. 2010 Feb;119(1):83-92
pubmed: 20141245
Annu Rev Psychol. 2001;52:59-82
pubmed: 11148299
Schizophr Bull. 2011 Mar;37(2):244-7
pubmed: 21224492
Arch Gen Psychiatry. 2009 Mar;66(3):236-47
pubmed: 19255373
Cochrane Database Syst Rev. 2013 Oct 18;(10):CD008704
pubmed: 24142844
J Clin Psychol. 2017 May;73(5):579-589
pubmed: 28152198
Assessment. 2020 Sep 10;:1073191120957102
pubmed: 32909448
J Behav Ther Exp Psychiatry. 2014 Dec;45(4):441-6
pubmed: 24974215
Psychol Med. 2021 Jan;51(2):244-253
pubmed: 31744588
Br J Psychiatry Suppl. 2013 Jan;54:s30-5
pubmed: 23288499
Lancet Psychiatry. 2016 Jul;3(7):685-92
pubmed: 27371990
Transl Psychiatry. 2020 Jul 7;10(1):222
pubmed: 32636358
Am J Prev Med. 2007 May;32(5 Suppl):S112-8
pubmed: 17466815
Behav Ther. 2020 Jul;51(4):646-658
pubmed: 32586436
J Med Internet Res. 2019 Jul 22;21(7):e12869
pubmed: 31333198
Clin Psychol Psychother. 2017 Mar;24(2):348-358
pubmed: 26888312
Acta Psychiatr Scand. 2020 May;141(5):465-475
pubmed: 32027017
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Br J Psychiatry. 2017 Feb;210(2):140-148
pubmed: 27979820
Acta Psychiatr Scand. 2009 Jan;119(1):45-53
pubmed: 18822092
Psychol Med. 2008 Jan;38(1):101-11
pubmed: 17903336
Psychiatr Prax. 2018 Mar;45(2):59-61
pubmed: 29495051
Schizophr Bull. 2012 Nov;38(6):1288-96
pubmed: 22516147
Biol Psychiatry. 2005 Jul 15;58(2):105-10
pubmed: 16038680
Schizophr Bull. 2016 Mar;42(2):264-9
pubmed: 26707864
Lancet Public Health. 2018 Feb;3(2):e72-e81
pubmed: 29422189
Early Interv Psychiatry. 2019 Jun;13(3):379-386
pubmed: 28984077
Schizophr Bull. 2013 Nov;39(6):1281-7
pubmed: 23223342
Lancet Psychiatry. 2018 Oct;5(10):845-854
pubmed: 30170964
JMIR Mhealth Uhealth. 2019 Jul 04;7(7):e11926
pubmed: 31274112
BMJ. 2008 Oct 22;337:a1937
pubmed: 18945728
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9
pubmed: 20855043
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1011-22
pubmed: 24919446
Psychol Med. 2015 Apr;45(5):927-45
pubmed: 25215860
Internet Interv. 2019 Oct 18;18:100286
pubmed: 31890633
Psychol Med. 1983 Aug;13(3):595-605
pubmed: 6622612
Psychol Med. 2015 Jan;45(2):345-60
pubmed: 25066533
Br J Clin Psychol. 2013 Jun;52(2):199-214
pubmed: 24215148
Psychol Med. 2014 Jan;44(2):407-19
pubmed: 23590972
Psychol Psychother. 2019 Jun;92(2):277-297
pubmed: 30924316
JAMA Psychiatry. 2019 Nov 1;76(11):1167-1175
pubmed: 31461129
Psychiatry Res. 2012 Dec 30;200(2-3):904-10
pubmed: 22884307
Schizophr Bull. 2016 May;42(3):712-22
pubmed: 26834027
Arch Gen Psychiatry. 2007 Jan;64(1):19-28
pubmed: 17199051
World Psychiatry. 2020 Jun;19(2):151-172
pubmed: 32394571
Psychol Med. 2011 Nov;41(11):2305-15
pubmed: 21733219
World Psychiatry. 2018 Jun;17(2):123-132
pubmed: 29856567
JMIR Mhealth Uhealth. 2020 Apr 2;8(4):e14897
pubmed: 32238332
Eur Child Adolesc Psychiatry. 2021 Apr;30(4):591-605
pubmed: 32405792
Behav Ther. 2017 Nov;48(6):778-792
pubmed: 29029675
World Psychiatry. 2018 Jun;17(2):133-142
pubmed: 29856558
Psychol Med. 2012 Sep;42(9):1835-45
pubmed: 22225783
Early Interv Psychiatry. 2018 Feb;12(1):3-14
pubmed: 28782283
Clin Psychol Rev. 2010 Apr;30(3):349-62
pubmed: 20116915
Lancet. 2011 Jun 18;377(9783):2093-102
pubmed: 21652063
Schizophr Bull. 2017 Mar 1;43(2):302-315
pubmed: 28204708
Psychol Med. 2015 May;45(7):1551-63
pubmed: 25534496
Psychol Med. 2009 Sep;39(9):1533-47
pubmed: 19215626
JMIR Ment Health. 2019 Jun 26;6(6):e13717
pubmed: 31244479
J Affect Disord. 2004 Apr;79(1-3):33-41
pubmed: 15023478
Psychol Assess. 2009 Dec;21(4):498-505
pubmed: 19947784
Lancet. 2012 Jan 7;379(9810):27-8; author reply 28
pubmed: 22225664
Psychol Med. 2009 Jul;39(7):1077-86
pubmed: 18834553
J Behav Ther Exp Psychiatry. 2016 Mar;50:257-63
pubmed: 26480469
Cognit Ther Res. 2017;41(3):369-380
pubmed: 28515538
Soc Psychiatry Psychiatr Epidemiol. 2015 Jun;50(6):851-66
pubmed: 25982479